Real-world validation of the minimal disease activity index in psoriatic arthritis: an analysis from a prospective, observational, biological treatment registry

OBJECTIVE: To describe the minimal disease activity (MDA) rate over time in patients with psoriatic arthritis (PsA) receiving antitumour necrosis factor agents, evaluate prognostic factors of MDA achievement and identify the most common unmet criteria among MDA achievers. DESIGN: Biologic Treatment...

Descripción completa

Detalles Bibliográficos
Autores principales: Rahman, Proton, Zummer, Michel, Bessette, Louis, Baer, Philip, Haraoui, Boulos, Chow, Andrew, Kelsall, John, Kapur, Suneil, Rampakakis, Emmanouil, Psaradellis, Eliofotisti, Lehman, Allen J, Nantel, Francois, Osborne, Brendan, Tkaczyk, Cathy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2017
Materias:
Rheumatology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5629663/
https://www.ncbi.nlm.nih.gov/pubmed/28855200
http://dx.doi.org/10.1136/bmjopen-2017-016619

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5629663/
https://www.ncbi.nlm.nih.gov/pubmed/28855200
http://dx.doi.org/10.1136/bmjopen-2017-016619

Ejemplares similares